Skip to main content
锦好医疗 logo

锦好医疗 — Investor Relations & Filings

Ticker · 920925 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 568 across all filing types
Latest filing 2022-08-02 Board/Management Inform…
Country CN China
Listing Beijing Stock Exchange 920925

About 锦好医疗

https://www.jinghao.cn/

Jinghao Medical specializes in the research, development, and manufacturing of hearing aids and home medical electronic products. The company's core portfolio includes digital and analog hearing aids, medical nebulizers, and electronic blood pressure monitors. It focuses on providing hearing health solutions by integrating advanced digital signal processing technology into its devices. Jinghao Medical operates extensively in the global market, offering original design manufacturing (ODM) and original equipment manufacturing (OEM) services to international partners. The organization emphasizes technological innovation and maintains rigorous quality management systems to comply with international medical device standards. Its primary objective is to deliver accessible, high-performance medical equipment designed to improve the quality of life for users with hearing loss and other chronic health conditions.

Recent filings

Filing Released Lang Actions
独立董事关于第二届董事会第十八次会议有关事项的独立意见
Board/Management Information Classification · 95% confidence The document is a short announcement (586 characters) containing an independent director's opinion on a board meeting matter related to the company's 2022 equity incentive plan. It references internal governance procedures and approvals but does not contain financial statements or detailed financial data. It is not a full report but an announcement of a board-related opinion on a specific agenda item. This fits best under Board/Management Information (MANG) as it relates to board meeting decisions and opinions on company management matters.
2022-08-02 Chinese
关于调整2022年股权激励计划首次授予及预留股票期权行权价格与预留限制性股票授予价格的公告
Board/Management Information Classification · 95% confidence The document is an official announcement from Huizhou Jin Hao Medical Technology Co., Ltd. regarding adjustments to the exercise price of stock options and the grant price of reserved restricted stocks under the 2022 equity incentive plan. It details board and shareholder meeting approvals, legal opinions, and the rationale for price adjustments due to dividend distribution. The document is a formal announcement about changes to the equity incentive plan terms, not a full report or financial statement. It does not contain comprehensive financial data or results but focuses on governance and management decisions related to stock incentives. Therefore, it fits best under the category of Board/Management Information (MANG), which covers announcements of changes in company management or board-related decisions, including equity incentive plan adjustments.
2022-08-02 Chinese
关于惠州市锦好医疗科技股份有限公司2022年股权激励计划之首次授予及预留股票期权行权价格与预留限制性股票授予价格调整事项的法律意见书
Regulatory Filings Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the 2022 stock option and restricted stock incentive plan of Huizhou Jinhao Medical Technology Co., Ltd. It discusses the legal compliance and approval of adjustments to the exercise price and grant price of stock options and restricted stocks. The document is not a financial report, earnings release, or regulatory filing but a legal opinion related to a stock incentive plan. It does not fit into categories like Annual Report, Interim Report, or Capital/Financing Update. It is a specialized legal opinion document related to stock incentive plans, which is best classified under Regulatory Filings (RNS) as it does not match other more specific categories and is a legal compliance document rather than a financial or management report.
2022-08-02 Chinese
关于接待机构投资者调研情况的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement about a recent investor research visit and the company's responses to various operational and strategic questions. It includes details about business performance, product development, sales channels, and capacity planning. The document is relatively short (1847 characters) and does not contain financial statements or detailed financial data. It is not a full financial report like an Annual Report (10-K) or Interim Report (IR). It is also not a transcript of a call, nor a regulatory filing or legal proceeding. The content is focused on investor relations and company updates in response to investor inquiries, which aligns with a Regulatory Filing (RNS) as a general announcement that does not fit other specific categories. Therefore, the best classification is Regulatory Filings (RNS).
2022-07-21 Chinese
2022年股权激励计划股票期权授予结果公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the results of a stock option grant under an equity incentive plan by Huizhou Jin Hao Medical Technology Co., Ltd. It details the number of options granted, recipients, exercise conditions, and the impact on the company's financials. It is not a full financial report but a specific announcement about stock option grants and related details. This fits the category of Capital/Financing Update (CAP), as it relates to company financing activities and equity incentives. The document length is 3507 characters, which is consistent with an announcement rather than a full report. Therefore, the appropriate classification is CAP with high confidence.
2022-05-31 Chinese
2021年年度权益分派实施公告
Notice of Dividend Amount Classification · 100% confidence The document is an announcement regarding the implementation of the 2021 annual equity distribution (dividend) plan approved at the shareholders' meeting. It details the dividend amount, payment dates, tax treatment, and related procedural information. The document is short (1539 characters) and primarily serves to inform shareholders about dividend distribution specifics rather than presenting financial statements or comprehensive financial results. This fits the definition of a Notice of Dividend Amount (DIV) filing, which announces dividend amounts, payment dates, and details for shareholders.
2022-05-25 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.